HK Stock MarketDetailed Quotes

03320 CHINARES PHARMA

Watchlist
  • 4.990
  • +0.030+0.60%
Trading May 7 11:34 CST
31.35BMarket Cap8.66P/E (TTM)

CHINARES PHARMA Key Stats

CHINARES PHARMA Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: HKD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/H2-- / 146.860B--
--2025/H1-- / 143.876B--
Mar 26, 20252024/H2138.256B / 141.332B--
Aug 29, 20242024/H1141.282B / ----
Mar 26, 20242023/H2114.635B / 136.356B--
DatePeriodRevenue/EstimateEarnings Call
--2025/H2-- / 146.860B--
--2025/H1-- / 143.876B--
Mar 26, 20252024/H2138.256B / 141.332B--
Aug 29, 20242024/H1141.282B / ----
Mar 26, 20242023/H2114.635B / 136.356B--

Unlock Free Earnings Estimates

CHINARES PHARMA Earnings Reports

Read more

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More